About
Korsana Biosciences is a biotechnology company developing blood-brain barrier (BBB)-penetrant delivery technology and therapeutic candidates for neurodegenerative diseases. In partnership with Paragon Therapeutics it has developed the THETA™ BBB shuttle platform to enhance CNS exposure of investigational therapies and is advancing programs targeting Alzheimer’s disease.
Explore Korsana Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.